Literature DB >> 8458446

Laparoscopic surgery for ectopic pregnancies: technology assessment and public health implications.

F Maruri1, R Azziz.   

Abstract

OBJECTIVES: To review the process by which technology is assessed in the United States and to use the principles elicited to compare laparotomy versus laparoscopy for the treatment of ectopic pregnancies (EPs). PARTICIPANTS: Patients with an EP documented in 1987 in the United States.
METHODS: Determining and reviewing the applicability, safety, efficacy, cost-effectiveness, cost-benefit, and availability of laparoscopic surgery for an EP.
RESULTS: Laparoscopic surgery is applicable to at least 80% of patients, representing some 70,400 women in 1987. Safety and efficacy of laparoscopy are comparable with laparotomy, with the exception of a possible increase in the frequency of persistent EPs, if a conservative procedure is performed endoscopically. Dollar for dollar laparoscopy is more cost-effective than laparotomy for the treatment of EPs, with reduced hospitalization and recovery time, and improved cosmesis. Cost-benefit analysis indicates a savings of $105,600,000.00 in direct hospitalization costs and $65,000,000.00 in increased employer or patient income, because of a more rapid return to work time. Furthermore, savings in decreased home care requirements could not be calculated. The use of laparoscopic surgery in all potential candidates with an EP in 1987 would have resulted in an increased expenditure of $28,160,000.00 annually for additional equipment and $3,520,000.00 for the repeat laparotomies required to treat the excess number of persistent EPs. The expense of training physicians and operating room staffs in this technique could not be quantified. Overall, availability of this procedure was felt to be considerably less than 30% of affected patients.
CONCLUSIONS: Overall, the use of laparoscopic surgery in all eligible (> or = 80%) patients with an EP in 1987 in the United States would have resulted in a savings of approximately $138,920,000.00 for that year alone. Currently, there is a tremendous deficiency in the availability of this cost-effective procedure, contributing to the escalating costs of medical care.

Entities:  

Mesh:

Year:  1993        PMID: 8458446     DOI: 10.1016/s0015-0282(16)55787-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Rapid hospital discharge following laparoscopy for ectopic pregnancy. A promise unfulfilled?

Authors:  L A Learman; D A Grimes
Journal:  West J Med       Date:  1997-09

2.  Ovarian pregnancies after oocyte donation in three menopausal patients treated by laparoscopy.

Authors:  T Mantzavinos; N Kanakas; K Mavrelos
Journal:  J Assist Reprod Genet       Date:  1994-07       Impact factor: 3.412

3.  Ectopic pregnancy--becoming a nonsurgical disorder.

Authors:  E D Schriock
Journal:  West J Med       Date:  1993-08

4.  Methotrexate provides significant cost savings for the treatment of unruptured ectopic pregnancy.

Authors:  F Lecuru; J P Bernard; C Mac-Cordick; V Boucaya; R Taurelle
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

5.  Single-port laparoscopic salpingectomy for surgical treatment of tubal pregnancy: comparison with multi-port laparoscopic salpingectomy.

Authors:  Yong-Wook Kim; Byung-Joon Park; Tea-Eung Kim; Duck-Yeong Ro
Journal:  Int J Med Sci       Date:  2013-06-24       Impact factor: 3.738

6.  Laparoscopic management of tubal ectopic pregnancy.

Authors:  Dah-Ching Ding; Tang-Yuan Chu; Sheng-Po Kao; Pao-Chu Chen; Yu-Chi Wei
Journal:  JSLS       Date:  2008 Jul-Sep       Impact factor: 2.172

7.  Comparison of diagnostic accuracy of transvaginal ultrasound with laparoscopy in the management of patients with adnexal masses.

Authors:  Theodoros D Theodoridis; Leonidas Zepiridis; Themistoklis Mikos; Grigoris F Grimbizis; Konstantinos Dinas; Apostolos Athanasiadis; John N Bontis
Journal:  Arch Gynecol Obstet       Date:  2009-03-05       Impact factor: 2.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.